000			07198cam a2200601 i 4500
001			on1178869018
003			OCoLC
005			20250508013040.0
006			m d
007			cr cnu---unuuu
008			200722s2020 nyu ob 001 0 eng
010			_a 2020030184
040			_aDLC _beng _erda _cDLC _dOCLCO _dOCLCF _dYDX _dOCLCO _dEBLCP _dN$T
019			_a1231608450 _a1232276200 _a1235593815 _a1236266471 _a1237405609 _a1237866634
020			_a1536183695 _qelectronic book
020			_a9781536183696 _q(electronic bk.)
020			_z9781536182170 _qhardcover
035			_a2518337 _b(N$T)
035			_a(OCoLC)1178869018 _z(OCoLC)1231608450 _z(OCoLC)1232276200 _z(OCoLC)1235593815 _z(OCoLC)1236266471 _z(OCoLC)1237405609 _z(OCoLC)1237866634
042			_apcc
043			_an-us---
050	0	0	_aRM146.7 _b.S83 2020
082	0	0	_a362.29 _223
049			_aMAIN
245	0	4	_aThe opioid epidemic : _bmedical, nursing, counseling behavioral treatment / _cAlbert Anthony Rundio Jr., and Stephanie Brooks, editors.
264		1	_aNew York : _bNova Science Publishers, Incorporated, _c[2020]
300			_a1 online resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
490	1		_aSubstance abuse assessment, interventions and treatment
504			_aIncludes bibliographical references and index.
520			_a"The Opioid Epidemic is one of the major events that has occurred in the United States during the past few years. Several factors have contributed to this epidemic. Accrediting bodies identifying pain as the 5th Vital Sign certainly addressed patient's pain but also accelerated the use of prescription narcotic pain medications as first line therapy rather than utilizing other types of pharmacologic agents that are not narcotics as well as trying other non-pharmacologic interventions such as holistic health modalities. Dependent upon the type of narcotic pain medication prescribed, patients can develop a dependence upon the medication which then leads to addiction. Purchasing such medications can be rather expensive. Many patients then turn to purchasing less expensive drugs, such as Heroin, off of the street. Compounding the problem today is that much of the heroin is tainted with other drugs, such as Benzodiazepines and Fentanyl. Fentanyl is far more potent than heroin. The end result is that many young people as well as older people are dying from overdoses. If someone is not available to administer Naloxone immediately the end result is death. There have been many strategies implemented by both the federal government and individual states governments to combat the opioid epidemic. Many states have implemented Prescription Drug Monitoring Programs (PDMP) that report the prescriptions for controlled substances that a patient purchases. Legislation has been passed to promote addiction treatment centers and medicated assisted treatment programs. Although there has been a noted decreased in opioid related deaths, there is still a long way to go to combat this epidemic. Care rendered to the patient with opioid substance use disorders needs to be interprofessional and inclusive of Medicine, Nursing, Counseling and other behavioral modalities. Such interprofessional care will yield the best treatment outcomes"-- _cProvided by publisher.
588			_aDescription based on online resource; title from digital title page (viewed on January 11, 2021).
505	0		_aIntro -- Contents -- Preface -- Chapter 1 -- The Opioid Epidemic/SUD: Facts, Figures and Assessment Tools -- Abstract -- SBIRT (Screening Brief Intervention Referral to Treatment) -- Case Example -- Tools -- Screening for Alcohol Problems -- At-Risk Drinking -- A. WHO -- ASSIST V3.0 -- B. Who Assist V3.0 Response Card for Patients -- C. Alcohol, Smoking and Substance Involvement Screening Test (Who Assist V3.0) Feedback Report Card For Patients -- D. WHO Risks of Injecting Card -- Information for clients
505	8		_aE. Translation and Adaptation to Local Languages and Culture: A Resource for Clinicians and Researchers -- CAGE Questionnaire -- Scoring -- Clinical Opiate Withdrawal Scale (COWS) -- Flow-Sheet for Measuring Symptoms for Opiate Withdrawals over a Period of Time -- CRAFFT -- Objective Opioid Withdrawal Scale (OOWS) -- References -- Chapter 2 -- The Neurobiology of Opioid Drug Addiction -- Abstract -- Case Study -- Introduction and Overview -- The Physiology of Addiction -- Biologic Models of Addiction -- Tolerance and Reverse Tolerance -- Case Study Revisited -- References -- Chapter 3
505	8		_aPharmacologic Concepts in Opioid Addiction Treatment Through the Continuum -- Abstract -- Pharmacokinetics and Pharmacodynamics -- Case Study -- Part 1 -- Treatment of Opioid Overdose -- Case Study -- Part 2 -- Withdrawal Management from Opioid Drugs -- A Short History of the Detoxification Process -- Case Study -- Part 3 -- The Protracted Abstinence Syndrome -- Case Study -- Part 4 -- Medication Assisted Treatment -- Medications Used in Maintenance Treatment of Opioid Use Disorder -- Naltrexone -- Methadone -- Buprenorphine -- Case Study -- Epilogue -- References -- Chapter 4
505	8		_aMaternal Substance Use: Systemically Understanding Treatment and Recovery -- Abstract -- Introduction -- Key Concepts in Maternal Substance Use -- Prevalence and Correlates of Maternal Substance Use -- Considering the Family Unit -- Treatment Barriers for Maternal SUD -- Cultural and Social Justice Considerations -- Gender -- Race and Ethnicity -- Considering Intersectionality -- Best Practices for Assessing and Treating Maternal Substance Use -- Screening and Assessment -- AUDIT -- ASSIST -- CAGE and CAGE-AID -- Toxicology Testing -- Evidence-Based Practices -- Family-Centered Treatment
505	8		_aTrauma-Informed Care -- Parenting Education and SUDs -- Family Spirit Model (Center for American Indian Health at the Bloomberg School of Public Health at Johns Hopkins University) -- Celebrating Families! (National Association for Children of Addiction, 2007) -- Trauma and SUDs -- Helping Women Recover: A Program for Treatment Addiction, Special Criminal Justice Edition (HWR) (Covington, 2000) -- Seeking Safety (Najavits, Weiss, Shaw, and Muenz, 1998) -- Opioid Use Disorders -- Limitations of Current Treatment Models for Maternal Substance Use -- Case Example: Mary -- Treatment Considerations for Mary
650		0	_aOpioid abuse _xUnited States.
650		0	_aMedication abuse _zUnited States.
650		0	_aSubstance abuse _zUnited States.
650		0	_aSubstance abuse _xTreatment _zUnited States.
650		0	_aSubstance abuse _xAlternative treatment _zUnited States.
650		0	_aSubstance abuse _zUnited States _xPsychological aspects.
700	1		_aRundio, Albert Anthony, _eeditor.
830		0	_aSubstance abuse assessment, interventions and treatment series.
856	4	0	_3EBSCOhost (requires login) _uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2518337
938			_aProQuest Ebook Central _bEBLB _nEBL6373323
938			_aEBSCOhost _bEBSC _n2518337
942			_cCF
994			_a92 _bN$T
999			_c1957 _d1957